Integrum AB (publ)
INTEG-B
Rank in Stocks
#25856
Integrum AB (publ) focuses on the research, development, and global sale of... Integrum AB (publ) focuses on the research, development, and global sale of advanced bone-anchored prosthetic solutions. A core offering is the Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant system. This innovative bone-anchored prosthesis integrates directly with the patient's bone through osseointegration, thus circumventing the need for a conventional socket. A significant benefit of the OPRA system is its protective quality, helping to prevent bone fractures from accidental loads. Additionally, Integrum provides Neuromotus, a therapeutic technology designed to mitigate phantom limb pain following an amputation. These sophisticated implant systems are distributed worldwide to hospitals, clinics, and orthopedic professionals. The company was founded in 1962 and is based in Mölndal, Sweden.
Share Price
$0.82029017
Last synced: 2026-11-09
Market Cap
$23.54M
Change (1 day)
0.54%
Change (1 year)
-7.96%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Integrum AB (publ) (INTEG-B)
Category
Healthcare
Operating Margin for Integrum AB (publ) (INTEG-B)
Operating Margin as of November 2026 TTM: -38.05%
According to Integrum AB (publ)'s latest financial reports, its current operating margin (TTM) is -38.05%. At the end of 2025 the company had an operating margin of -46.51%.
Operating Margin history for Integrum AB (publ) from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -38.05% | -18.19% |
| 2025 | -46.51% | -844.16% |
| 2024 | 6.25% | -123.56% |
| 2023 | -26.53% | -1,526.34% |
| 2022 | 1.86% | -143.26% |
| 2021 | -4.30% | -92.67% |
| 2020 | -58.63% | -46.45% |
| 2019 | -109.49% | -11.51% |
| 2018 | -123.73% | 259.47% |
| 2017 | -34.42% | -2,292.36% |
| 2016 | 1.57% | -129.24% |
| 2015 | -5.37% | -133.82% |
| 2014 | 15.88% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.40% |
US
|
|
| 18.08% | -100.48% |
IE
|
|
| 21.25% | -100.56% |
US
|
|
| 21.05% | -100.55% |
US
|
|
| 28.09% | -100.74% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Integrum AB (publ)'s operating margin
What is Integrum AB (publ)'s operating margin?
Integrum AB (publ)'s operating margin is -38.05%, as of Nov 2026.
What was Integrum AB (publ)'s operating margin in 2025?
In 2025, Integrum AB (publ)'s operating margin was -46.51%, compared with 6.25% in 2024.
How has Integrum AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Integrum AB (publ)'s operating margin was highest in 2024 (6.25%) and lowest in 2020 (-58.63%).
How does Integrum AB (publ)'s operating margin compare with similar companies?
Integrum AB (publ)'s operating margin (-38.05%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.